Connect Biopharma Holdings (CNTB) Net Equity Issued and Repurchased (2025 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Net Equity Issued and Repurchased of $137000.0 for Q1 2026, up 6750.0% year-on-year from $2000.0 in Q1 2025, and up 6750.0% on a QoQ basis from $2000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $137000.0 the latest figure, recorded in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - | 137,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 137,000.00 |
| Mar 31, 2026 | 137,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |